Oral semaglutide (Rybelsus) is typically held only on the day of surgery
Al Musaimi O, Ng KW, Gavva V, Mercado-Valenzo OM, Haroon HB, Williams DR
KEY OBSERVATIONS Cold-chain packaging was solid
Therefore, it is structurally and pharmacologically distinct from earlier dual-receptor compounds like Tirzepatide (GLP-1 + GIP) and single-receptor compounds like Semaglutide (GLP-1 only)
Building on the momentum of the GLP-1 space and beyond, companies including Eli Lilly, Pfizer, Novo Nordisk, and Amgen have all introduced DTP platforms
Lipids are commonly checked before starting therapy, then around two to three months after a dose change, and periodically afterward based on risk